Eupraxia Pharmaceuticals Inc. (EPRX) Dividend History

Company News

• Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders

  Eupraxia Pharmaceuticals announced the results of its Annual General and Special Meeting of Shareholders, where all six proposed directors were elected, and other business items were approved by shareholders.

  GlobeNewswire Inc.
• Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

  Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations. Esperion Therapeutics shares climbed 7.1% to $3.47 pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Longeveron Inc. (NASDAQ: LGVN) rose 93.2% to $4.25 in pre-market trading after gaining 8% on Friday. Antelope Enterprise Holdings Limited (NASDAQ: AEHL) shares rose 47% to $2.20 in pre-market trading after declining 5% on Friday. On April 1, Antelope Enterprise announced preliminary full year 2023 revenue of $70.4 million. DigiAsia Corp. (NASDAQ: FAAS) shares rose 31.6% to $8.46 in pre-market trading after the jumping around 17% on Friday. BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) gained 27.2% to $1.31 in pre-market trading. Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 25.6% to $0.2840 in pre-market trading after dipping over 8% on ...

  Benzinga

  Featured Companies: AEHL ALLR AUUD BRCC CCTG DXYZ ESPR FAAS FLGC GLMD GVH LGVN MDIA MSTR NCPL RELI XXII ZOOZ